STOCK TITAN

Accuray to Report First Quarter Fiscal 2022 Financial Results on November 3, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

SUNNYVALE, Calif., Oct. 13, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2022, ended September 30, 2021, after the market close on Wednesday, November 3, 2021. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. ET on the same day.

The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (International). In addition, a dial up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is (877) 344-7529 (USA), or (412) 317-0088 (International), Conference ID: 10161091.

A live webcast of the call will also be available from the Investor Relations section of the Company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the second quarter of fiscal 2022.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale, California, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, Twitter, and YouTube.

Contacts:


Beth Kaplan

Joe Diaz

Public Relations Director

Investor Relations

(408) 789-4426

(602) 717-7804

bkaplan@accuray.com 

jdiaz@accuray.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-first-quarter-fiscal-2022-financial-results-on-november-3-2021-301398955.html

SOURCE Accuray Incorporated

Accuray Inc

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Sunnyvale

About ARAY

accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.